122 related articles for article (PubMed ID: 3874629)
1. 2-[3-(1,1-Dimethylethyl)-5-methoxyphenyloxazolo[4,5-b]pyridine, a new topical antiinflammatory and analgesic compound lacking systemic activity and gastric side effects.
Bonney RJ; Olson BJ; Bach T; Beveridge G; Goldenberg MM; Gitterman CO; Humes JL; Lu AY; Hucker H; Dougherty H
Arzneimittelforschung; 1985; 35(4):715-20. PubMed ID: 3874629
[TBL] [Abstract][Full Text] [Related]
2. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M
Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of droxicam, a new non-steroidal anti-inflammatory agent.
Farré AJ; Colombo M; Fort M; Gutiérrez B; Rodríguez L; Roser R
Methods Find Exp Clin Pharmacol; 1986 Jul; 8(7):407-22. PubMed ID: 3489870
[TBL] [Abstract][Full Text] [Related]
4. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory, analgesic, and antipyretic effects and gastrointestinal toxicity of the new anti-inflammatory drug N-(3-[3-(piperidinylmethyl)phenoxy]propyl)-carbamoylmethylthio ]ethyl 1-(p-chlorobenzoyl) 5-methoxy-2-methyl-3-indolylacetate.
Segawa Y; Ohya O; Abe T; Omata T; Tsuzuike N; Itokazu Y; Yoshida K; Tagashira E; Ueda I
Arzneimittelforschung; 1992 Jul; 42(7):954-8. PubMed ID: 1418061
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological studies of the new antiinflammatory agent 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-o ne. 1st communication: antiinflammatory, analgesic and other related properties.
Tanaka K; Shimotori T; Makino S; Aikawa Y; Inaba T; Yoshida C; Takano S
Arzneimittelforschung; 1992 Jul; 42(7):935-44. PubMed ID: 1418059
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of pravadoline: a new analgesic agent.
Haubrich DR; Ward SJ; Baizman E; Bell MR; Bradford J; Ferrari R; Miller M; Perrone M; Pierson AK; Saelens JK
J Pharmacol Exp Ther; 1990 Nov; 255(2):511-22. PubMed ID: 2243340
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 2nd communication: inhibitory effects on acute inflammation and prostaglandin-related reactions.
Tsurumi K; Kyuki K; Niwa M; Mibu H; Fujimura H
Arzneimittelforschung; 1986 Dec; 36(12):1801-5. PubMed ID: 3105545
[TBL] [Abstract][Full Text] [Related]
10. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach.
Chan CC; Boyce S; Brideau C; Ford-Hutchinson AW; Gordon R; Guay D; Hill RG; Li CS; Mancini J; Penneton M
J Pharmacol Exp Ther; 1995 Sep; 274(3):1531-7. PubMed ID: 7562530
[TBL] [Abstract][Full Text] [Related]
12. Characterization of 5-[5-(4-chlorophenyl-2-furanyl)]dihydro-2(3H)-furanone as a nonsteroidal antiinflammatory drug.
Brooks RR; Miller KE; Pelosi SS; Pong SF; Anthony DR; Goldenberg MM
Arzneimittelforschung; 1988 Jan; 38(1):59-65. PubMed ID: 3365279
[TBL] [Abstract][Full Text] [Related]
13. Fuscoside: an anti-inflammatory marine natural product which selectively inhibits 5-lipoxygenase. Part I: Physiological and biochemical studies in murine inflammatory models.
Jacobson PB; Jacobs RS
J Pharmacol Exp Ther; 1992 Aug; 262(2):866-73. PubMed ID: 1501127
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological studies of a new non-steroidal antiinflammatory drug: 2-(5-ethylpyridin-2-yl)benzimidazole (KB-1043).
Ito K; Kagaya H; Fukuda T; Yoshino K; Nose T
Arzneimittelforschung; 1982; 32(1):49-55. PubMed ID: 6977364
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and analgesic activity of new tricyclic pyrazolo[3,4-b]pyridines.
Winters G; Schiatti P; Selva D
Farmaco Sci; 1985 Nov; 40(11):845-53. PubMed ID: 3878799
[TBL] [Abstract][Full Text] [Related]
17. [Anti-inflammatory and analgesic activities of a trans-cutaneous non-steroidal anti-inflammatory agent, etofenamate gel].
Nakamura H; Yokoyama Y; Motoyoshi S; Seto Y; Ishii K; Imazu C; Kadokawa T; Shimizu M
Nihon Yakurigaku Zasshi; 1982 Aug; 80(2):183-94. PubMed ID: 7173741
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.
Song Y; Connor DT; Sercel AD; Sorenson RJ; Doubleday R; Unangst PC; Roth BD; Beylin VG; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
J Med Chem; 1999 Apr; 42(7):1161-9. PubMed ID: 10197960
[TBL] [Abstract][Full Text] [Related]
19. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
20. The pharmacological properties of fenbufen. A review.
Sloboda AE; Tolman EL; Osterberg AC; Panagides J
Arzneimittelforschung; 1980; 30(4A):716-21. PubMed ID: 7002162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
